Home › Funds › WELLINGTON MANAGEMENT GROUP LLP › ELV

WELLINGTON MANAGEMENT GROUP LLP position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

WELLINGTON MANAGEMENT GROUP LLP reported holding 9,213,513 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$3.56B, representing 0.68% of its reported portfolio and ranking #20 among its reported holdings. WELLINGTON MANAGEMENT GROUP LLP has disclosed ELV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)9.21M sh
Reported value held$3.56B
Portfolio Weight0.68%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How WELLINGTON MANAGEMENT GROUP LLP's ELV position evolved

WELLINGTON MANAGEMENT GROUP LLP first disclosed a stake in ELV in Q3 2023 at 6,592,766 shares (US$2.87B). The position peaked in Q2 2026 at 9,213,513 shares, worth US$3.56B. Across 12 filings, WELLINGTON MANAGEMENT GROUP LLP increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 9,213,513 shares valued at US$3.56B — an increase of 984,976 shares quarter over quarter.. Notable position changes include a 42% increase in Q4 2024 (shares rose 18% over the following quarter), a 25% increase in Q4 2025 (shares fell 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 6.59M $2.87B New
Q4 2023 5.91M $2.79B Reduce
Q1 2024 4.50M $2.33B Reduce
Q2 2024 4.17M $2.26B Reduce
Q3 2024 4.46M $2.32B Add
Q4 2024 6.36M $2.34B Add
Q1 2025 5.79M $2.52B Reduce
Q2 2025 6.32M $2.46B Add
Q3 2025 6.62M $2.14B Add
Q4 2025 8.29M $2.91B Add
Q1 2026 8.23M $2.41B Reduce
Q2 2026 9.21M $3.56B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 22 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), Sanders Capital, LLC (US$2.25B), Harris Associates (Oakmark) (US$1.90B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has WELLINGTON MANAGEMENT GROUP LLP held ELV?

WELLINGTON MANAGEMENT GROUP LLP has disclosed ELV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is WELLINGTON MANAGEMENT GROUP LLP's current position in ELV?

As of Q2 2026, WELLINGTON MANAGEMENT GROUP LLP holds 9.21M shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $3.56B, representing 0.68% of its reported portfolio and ranking #20.

Has WELLINGTON MANAGEMENT GROUP LLP been buying or selling ELV?

In the latest 13F filing (Q2 2026), WELLINGTON MANAGEMENT GROUP LLP increased its position in ELV. The position peaked in Q2 2026 at 9.21M shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, Sanders Capital, LLC, Harris Associates (Oakmark), among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.